Try our Advanced Search for more refined results
USA v. Cadden et al
Case Number:
1:14-cr-10363
Court:
Nature of Suit:
Judge:
Firms
- Anderson & Kreiger
- Brody Hardoon
- Butters Brazilian
- Commisso Law
- Fitch Law Partners
- Greenberg Traurig
- Hinckley Allen
- Holland & Knight
- Husch Blackwell
- Jackson Lewis PC
- Kiernan Trebach
- Krattenmaker O'Connor
- Laredo & Smith
- Law Offices of Stephen J. Weymouth
- Libby Hoopes
- McDermott Will & Emery
- Michaels Ward
- Murphy & King
- Prince Lobel
- Todd & Weld
- Troutman Pepper
- WilmerHale
-
September 24, 2018
Prosecutors Can Tell 3rd NECC Jury About Meningitis Pain
Low-level pharmacists at the shuttered New England Compounding Center whose bosses have been convicted of causing a drug contamination that gave patients meningitis cannot preclude prosecutors from telling jurors next month about the horrendous pain caused by their supervisors, a Massachusetts federal judge ruled Monday.
-
May 09, 2018
Ex-Pharmacist Denied Meningitis Acquittal Bid Amid Appeal
A Massachusetts federal court reiterated Wednesday that a pharmacist convicted of 77 counts for manufacturing deadly drugs in the 2012 fungal meningitis outbreak cannot pursue an acquittal bid while simultaneously appealing the verdict.
-
April 30, 2018
Ex-NECC Employees Don't Want Jury To Hear Of Drug Harms
New England Compounding Center pharmacists and other former employees facing mail fraud charges as a result of the infamous 2012 fungal meningitis outbreak told a Massachusetts federal judge Monday that the jury at their upcoming trial should not hear about the harm caused by the center's tainted drugs, arguing it would lead the panel to act on emotion.
-
March 21, 2018
Meningitis Pharmacist's Direct Victims Were Providers: Judge
A former New England Compounding Center pharmacist convicted of racketeering only has to provide restitution to hospitals and doctors that purchased his contaminated drugs, not patients and other victims of a subsequent meningitis outbreak, a Massachusetts federal judge said Tuesday.
-
February 23, 2018
Meningitis Pharmacist Must Forfeit $175K Before Restitution
A former Massachusetts pharmacist convicted of recklessly mixing drugs that led to a 2012 meningitis outbreak must forfeit $175,000, or less than one-half of his salary from the roughly three years a jury decided his laboratory degenerated into a criminal enterprise, a federal judge decided on Friday.
-
February 13, 2018
Meningitis Pharmacist Tells Court Restitution Is Too Much
The pharmacist who oversaw a sloppy drug compounding operation that churned out moldy steroid injections and led to a fatal meningitis outbreak said Monday that he shouldn't have to forfeit his entire six-year salary of $611,000 now that he has been sentenced to eight years of prison.
-
January 31, 2018
Pharmacist Gets 8 Years For Making Meningitis-Linked Drugs
The second pharmacist convicted of racketeering and fraud that led to a deadly meningitis outbreak will spend eight years in prison — one year less than his boss, a federal judge in Massachusetts decided Wednesday.
-
January 29, 2018
Pharmacist Should Pay Meningitis Victims $82M, Gov't Says
The United States urged a Massachusetts federal judge Friday to order a former New England Compounding Center pharmacist to pay $82 million in restitution to victims of a 2012 deadly meningitis outbreak tied to the pharmacy.
-
January 12, 2018
1st Circ. Sends 3 More Meningitis Pharmacists To Trial
The First Circuit on Friday decided federal prosecutors can move forward with charges against three former pharmacists who allegedly prescribed drugs to "Wonder Woman," "Chester Cheeto," "Filet O'fish" and other fake patients from a Massachusetts compounding facility linked to a fatal meningitis outbreak.
-
December 14, 2017
Meningitis Fraudster Says Feds' Push For $133M Must Wait
A pharmacist convicted of fraud for selling deadly drugs in the 2012 fungal meningitis outbreak urged a Massachusetts federal court Wednesday to uphold its decision not to award the federal government $132.8 million in restitution while he appeals his case to the First Circuit.